IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Iambic Therapeutics, Inc.
$16.34−7.47 (-31.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Statistics
Not enough reported data
Statistics need Iambic Therapeutics's reported income statement and balance sheet.